Pay in 4 interest-free payments of $5.55 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
A 12-week clinical trial showed subjects taking AOD-9604 (1 mg/d) lost an average of 2.6 kg, compared to 0.8 kg in the placebo group.
It is designated solely as a research chemical
Urine organic acid analysis for inherited metabolic disease using gas chromatography-mass spectrometry
This allows researchers to reconstitute lyophilised compounds and draw multiple doses from a single vial over an extended period without compromising sterility or compound integrity a critical advantage over standard sterile water, which is limited to single-use applications
Potential pancreatitis risk : As with other GLP-1-based therapies, there is a theoretical concern regarding pancreatitis, though causality has not been firmly established in trials to date
Barsness, G
